Modeling & Simulation Workshop – China​

Caroline is a Portfolio Account Manager at Certara specializing in modeling and simulation, including QSP, PBPK, and Pharmacometrics. She joined Certara via the acquisition of Applied BioMath, which focused on QSP for complex biologics. With a background in biochemistry and medicine, she is passionate about accelerating better therapeutics to patients through modeling and simulation.

Jia Ning, PhD joined Certara’s Simcyp group in 2019. She is primarily responsible for establishing PBPK models for drugs, predicting drug-drug interactions (DDI), and predicting pharmacokinetics (PK) in special populations.

She conducted research at Wageningen University in the Netherlands from 2015 to 2019. She excels in using PBPK models to predict hepatotoxicity of drugs and comparing differences between species and ethnic groups.

Dr. Lin is Senior Director of Pharmacometrics and APAC Quantitative Sciences Solutions Team Lead, with extensive experience applying model-informed drug development to support dose optimization, regulatory strategy, and clinical decision-making across oncology, biologics, ADCs, infectious diseases, and other complex therapeutic areas.

Ruijuan graduated from East China Normal University and is a visiting scholar at the University of Houston, USA. She is an expert in bioinformatics, with rich working experience in disease detection and drug development. Currently, she is responsible for the consulting service for drug development-related software at Certara and possesses profound knowledge and experience in utilizing Pinnacle 21 Enterprise (P21E) to ensure data compliance with CDISC standards.